Market Closed -
Bombay S.E.
06:00:51 2024-05-23 am EDT
|
5-day change
|
1st Jan Change
|
68.1
INR
|
-1.72%
|
|
+0.89%
|
-7.80%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
6,174
|
5,006
|
4,295
|
7,456
|
16,112
|
16,267
|
Enterprise Value (EV)
1 |
8,476
|
7,042
|
6,136
|
8,746
|
20,697
|
23,092
|
P/E ratio
|
53.5
x
|
-67.3
x
|
22.4
x
|
14.4
x
|
22
x
|
17.2
x
|
Yield
|
0.32%
|
-
|
0.45%
|
1.05%
|
0.68%
|
0.86%
|
Capitalization / Revenue
|
0.73
x
|
0.58
x
|
0.42
x
|
0.63
x
|
0.98
x
|
0.77
x
|
EV / Revenue
|
1
x
|
0.81
x
|
0.6
x
|
0.73
x
|
1.26
x
|
1.09
x
|
EV / EBITDA
|
17.7
x
|
42.9
x
|
9.3
x
|
7.77
x
|
14.9
x
|
12.1
x
|
EV / FCF
|
-27.3
x
|
-25.9
x
|
-50.4
x
|
15.8
x
|
-5.91
x
|
-10.2
x
|
FCF Yield
|
-3.67%
|
-3.87%
|
-1.98%
|
6.32%
|
-16.9%
|
-9.8%
|
Price to Book
|
2.58
x
|
1.76
x
|
1.2
x
|
1.78
x
|
3.3
x
|
2.83
x
|
Nbr of stocks (in thousands)
|
156,308
|
167,420
|
192,605
|
196,218
|
198,307
|
198,842
|
Reference price
2 |
39.50
|
29.90
|
22.30
|
38.00
|
81.25
|
81.81
|
Announcement Date
|
7/14/18
|
7/21/19
|
9/6/20
|
9/2/21
|
9/7/22
|
9/1/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
8,467
|
8,655
|
10,180
|
11,914
|
16,402
|
21,155
|
EBITDA
1 |
479.8
|
164
|
659.5
|
1,126
|
1,388
|
1,904
|
EBIT
1 |
314.7
|
-1.5
|
492.3
|
923.8
|
1,173
|
1,663
|
Operating Margin
|
3.72%
|
-0.02%
|
4.84%
|
7.75%
|
7.15%
|
7.86%
|
Earnings before Tax (EBT)
1 |
154.3
|
-134.9
|
239.1
|
746.6
|
998.4
|
1,284
|
Net income
1 |
115.7
|
-69.5
|
167.4
|
509.9
|
734.2
|
948.7
|
Net margin
|
1.37%
|
-0.8%
|
1.64%
|
4.28%
|
4.48%
|
4.48%
|
EPS
2 |
0.7384
|
-0.4440
|
0.9963
|
2.630
|
3.700
|
4.770
|
Free Cash Flow
1 |
-310.8
|
-272.2
|
-121.6
|
553.1
|
-3,503
|
-2,263
|
FCF margin
|
-3.67%
|
-3.15%
|
-1.19%
|
4.64%
|
-21.36%
|
-10.7%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
49.11%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
108.47%
|
-
|
-
|
Dividend per Share
2 |
0.1250
|
-
|
0.1000
|
0.4000
|
0.5500
|
0.7000
|
Announcement Date
|
7/14/18
|
7/21/19
|
9/6/20
|
9/2/21
|
9/7/22
|
9/1/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,302
|
2,036
|
1,841
|
1,290
|
4,585
|
6,825
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.797
x
|
12.42
x
|
2.792
x
|
1.145
x
|
3.304
x
|
3.585
x
|
Free Cash Flow
1 |
-311
|
-272
|
-122
|
553
|
-3,503
|
-2,263
|
ROE (net income / shareholders' equity)
|
4.94%
|
-2.66%
|
5.22%
|
13.1%
|
16.2%
|
17.9%
|
ROA (Net income/ Total Assets)
|
2.88%
|
-0.01%
|
3.63%
|
5.98%
|
5.9%
|
6.06%
|
Assets
1 |
4,012
|
542,969
|
4,616
|
8,523
|
12,449
|
15,657
|
Book Value Per Share
2 |
15.30
|
17.00
|
18.50
|
21.30
|
24.60
|
28.90
|
Cash Flow per Share
2 |
0.4300
|
0.4100
|
4.340
|
3.470
|
3.530
|
2.090
|
Capex
1 |
134
|
225
|
699
|
160
|
1,379
|
1,455
|
Capex / Sales
|
1.58%
|
2.6%
|
6.87%
|
1.34%
|
8.41%
|
6.88%
|
Announcement Date
|
7/14/18
|
7/21/19
|
9/6/20
|
9/2/21
|
9/7/22
|
9/1/23
|
|
1st Jan change
|
Capi.
|
---|
| -7.80% | 166M | | -0.48% | 3.53B | | -23.09% | 2.07B | | -7.93% | 1.96B | | -0.55% | 1.81B | | -0.66% | 1.69B | | -9.39% | 1.29B | | +4.48% | 1.19B | | -20.89% | 1.05B | | -5.40% | 979M |
Pesticide
|